CN115925667A - A ratio-type near-infrared fluorescent probe molecule and its preparation method and application - Google Patents
A ratio-type near-infrared fluorescent probe molecule and its preparation method and application Download PDFInfo
- Publication number
- CN115925667A CN115925667A CN202211280811.2A CN202211280811A CN115925667A CN 115925667 A CN115925667 A CN 115925667A CN 202211280811 A CN202211280811 A CN 202211280811A CN 115925667 A CN115925667 A CN 115925667A
- Authority
- CN
- China
- Prior art keywords
- synthesis
- hours
- fluorescent probe
- substituted
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 238000003384 imaging method Methods 0.000 claims abstract description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 36
- 238000003786 synthesis reaction Methods 0.000 claims description 36
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 claims description 34
- 238000001816 cooling Methods 0.000 claims description 29
- 239000013067 intermediate product Substances 0.000 claims description 27
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 26
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 24
- WFDIJRYMOXRFFG-UHFFFAOYSA-N acetic acid anhydride Natural products CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 24
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 21
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 18
- 238000004440 column chromatography Methods 0.000 claims description 18
- 239000012074 organic phase Substances 0.000 claims description 18
- 239000007787 solid Substances 0.000 claims description 18
- -1 o-carboxyphenyl Chemical group 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 15
- 229910052757 nitrogen Inorganic materials 0.000 claims description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 12
- 239000005457 ice water Substances 0.000 claims description 12
- 239000012046 mixed solvent Substances 0.000 claims description 12
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 12
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 8
- VYXSBFYARXAAKO-WTKGSRSZSA-N chembl402140 Chemical class Cl.C1=2C=C(C)C(NCC)=CC=2OC2=C\C(=N/CC)C(C)=CC2=C1C1=CC=CC=C1C(=O)OCC VYXSBFYARXAAKO-WTKGSRSZSA-N 0.000 claims description 8
- 229940125904 compound 1 Drugs 0.000 claims description 8
- 229910052760 oxygen Inorganic materials 0.000 claims description 8
- 229940125782 compound 2 Drugs 0.000 claims description 7
- 239000002244 precipitate Substances 0.000 claims description 7
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical class CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims description 6
- QGMGHALXLXKCBD-UHFFFAOYSA-N 4-amino-n-(2-aminophenyl)benzamide Chemical compound C1=CC(N)=CC=C1C(=O)NC1=CC=CC=C1N QGMGHALXLXKCBD-UHFFFAOYSA-N 0.000 claims description 6
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 229940118019 malondialdehyde Drugs 0.000 claims description 6
- 239000011259 mixed solution Substances 0.000 claims description 6
- 238000010791 quenching Methods 0.000 claims description 6
- 230000000171 quenching effect Effects 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 5
- 229910020366 ClO 4 Inorganic materials 0.000 claims description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 4
- 229940126214 compound 3 Drugs 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 150000007530 organic bases Chemical class 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 4
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 3
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims description 3
- 238000004458 analytical method Methods 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims 1
- 150000002576 ketones Chemical class 0.000 claims 1
- 239000000758 substrate Substances 0.000 abstract description 4
- 239000012620 biological material Substances 0.000 abstract description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 14
- 206010028980 Neoplasm Diseases 0.000 description 11
- 102000004459 Nitroreductase Human genes 0.000 description 9
- 108020001162 nitroreductase Proteins 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- QQZOPKMRPOGIEB-UHFFFAOYSA-N n-butyl methyl ketone Natural products CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 8
- 239000003642 reactive oxygen metabolite Substances 0.000 description 8
- 230000004044 response Effects 0.000 description 8
- 238000001727 in vivo Methods 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- MHSGOABISYIYKP-UHFFFAOYSA-N (4-nitrophenyl)methyl carbonochloridate Chemical compound [O-][N+](=O)C1=CC=C(COC(Cl)=O)C=C1 MHSGOABISYIYKP-UHFFFAOYSA-N 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010067125 Liver injury Diseases 0.000 description 3
- 231100000753 hepatic injury Toxicity 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- RRWXWRCAEZWWCE-UHFFFAOYSA-N [4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl carbonochloridate Chemical compound O1C(C)(C)C(C)(C)OB1C1=CC=C(COC(Cl)=O)C=C1 RRWXWRCAEZWWCE-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 229910000530 Gallium indium arsenide Inorganic materials 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000011155 quantitative monitoring Methods 0.000 description 1
- 239000007845 reactive nitrogen species Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明属于生物材料技术领域,具体为一种比率型近红外荧光探针分子及其制备方法和应用。本发明的荧光探针分子,其结构通式见下面;该结构分子可构建选择性被特定底物激活的比率型近红外第二窗口荧光探针,用于生物体深组织成像、生物传感分析。
The invention belongs to the technical field of biological materials, in particular to a ratio-type near-infrared fluorescent probe molecule and its preparation method and application. The general structural formula of the fluorescent probe molecule of the present invention is as follows; the structural molecule can construct a ratiometric near-infrared second window fluorescent probe selectively activated by a specific substrate, which is used for deep tissue imaging and biosensing analyze.
Description
技术领域technical field
本发明属于生物材料技术领域,具体涉及一种比率型近红外荧光探针分子及其制备方法和其应用。The invention belongs to the technical field of biological materials, and in particular relates to a ratio-type near-infrared fluorescent probe molecule, a preparation method thereof, and an application thereof.
背景技术Background technique
近年来,近红外第二窗口(1000-1700nm)活体荧光成像在生物医学领域得到了快速的发展,这得益于InGaAs检测器(响应范围900-1700nm)的民用化。目前处于近红外第二窗口的荧光探针主要是“关-开”型探针,此类型荧光探针可以选择性被活体内的特定底物激活,从而给出信号,但它们只能实现“有”和“无”的信号改变,利用“关-开”型荧光探针可以实现对肿瘤微环境中特定底物如酶、活性氧/活性氮(ROS/RNS)定性的可视化监测,但不能实现定量变化的监测。In recent years, near-infrared second window (1000-1700nm) in vivo fluorescence imaging has been rapidly developed in the field of biomedicine, thanks to the civilian use of InGaAs detectors (response range 900-1700nm). At present, the fluorescent probes in the second near-infrared window are mainly "off-on" type probes, which can be selectively activated by specific substrates in vivo to give signals, but they can only achieve " With and without signal changes, the use of "off-on" fluorescent probes can achieve qualitative and visual monitoring of specific substrates such as enzymes, reactive oxygen species/reactive nitrogen species (ROS/RNS) in the tumor microenvironment, but cannot Realize quantitative change monitoring.
相比而言,比率型荧光探针由于可以通过多个通道采集信号,再把各通道信号进行关联,具有自我校正功能,可以实现定量分析监测。目前近红外第二窗口比率荧光探针和探针设计策略都比较少,且能实现检测的底物种类以强氧化性物质为主,不能满足对酶等生物分子的检测需求。为了实现对肿瘤微环境的量化可视化,急需构建近红外第二窗口比率型探针分子平台,建立深层组织下可靠的(半)定量分析方法。In contrast, ratiometric fluorescent probes can collect signals through multiple channels and then correlate the signals of each channel, which has a self-calibration function and can realize quantitative analysis and monitoring. At present, there are relatively few near-infrared second-window ratiometric fluorescent probes and probe design strategies, and the types of substrates that can be detected are mainly strong oxidizing substances, which cannot meet the detection requirements for enzymes and other biomolecules. In order to realize quantitative visualization of the tumor microenvironment, it is urgent to construct a near-infrared second window ratiometric probe molecular platform and establish a reliable (semi)quantitative analysis method under deep tissue.
发明内容Contents of the invention
本发明的目的在于提供一种能够对肿瘤微环境进行可视化、定量化监测的比率型近红外第二窗口荧光探针分子及其制备方法和应用。The object of the present invention is to provide a ratiometric near-infrared second window fluorescent probe molecule capable of visualizing and quantitatively monitoring the tumor microenvironment, its preparation method and application.
本发明提供的比率型近红外荧光探针分子,记为Rap,其化合物结构通式如下:The ratio-type near-infrared fluorescent probe molecule provided by the present invention is denoted as Rap, and its compound structural formula is as follows:
其中,X选自O或S;Y选自ClO4、PF6、BF4、Cl、Br、I、CF3COO、CF3SO3、CH3COO或CH3SO3;R1选自H、OH、OCH3或N[(CH2)nCH3]2;R2和R3为H、邻羧基苯基或苯基或邻甲基苯基,R4为取代苄氧基,可选自4-硝基苄氧基、4磷酸基苄氧基、4-谷氨酰转肽基苄氧基、4-β-半乳糖基苄氧基、叠氮基苄氧基、2,4-二硝基苄氧基、4-硼酸苄氧基或4-硼酸酯苄氧基,n为0~6的整数。Wherein, X is selected from O or S; Y is selected from ClO 4 , PF 6 , BF 4 , Cl, Br, I, CF 3 COO, CF 3 SO 3 , CH 3 COO or CH 3 SO 3 ; R 1 is selected from H , OH, OCH 3 or N[(CH 2 )nCH 3 ] 2 ; R 2 and R 3 are H, o-carboxyphenyl or phenyl or o-methylphenyl, R 4 is substituted benzyloxy, which can be selected from 4-nitrobenzyloxy, 4-phosphobenzyloxy, 4-glutamyl transpeptidylbenzyloxy, 4-β-galactosylbenzyloxy, azidobenzyloxy, 2,4-di Nitrobenzyloxy, 4-boronic acid benzyloxy or 4-boronic acid benzyloxy, n is an integer of 0-6.
本发明还提供上述比率型近红外荧光探针分子的制备方法,其合成路线为:The present invention also provides the preparation method of above-mentioned ratiometric near-infrared fluorescent probe molecule, and its synthetic route is:
其中,X选自O或S;Y选自ClO4、PF6、BF4、Cl、Br、I、CF3COO、CF3SO3、CH3COO或CH3SO3;R1选自H、OH、OCH3或N[(CH2)nCH3]2;R2和R3为H、邻羧基苯基或苯基或邻甲基苯基,,R4为取代苄氧基,可选自4-硝基苄氧基、4磷酸基苄氧基、4-谷氨酰转肽基苄氧基、4-β-半乳糖基苄氧基、叠氮基苄氧基、2,4-二硝基苄氧基、4-硼酸苄氧基或4-硼酸酯苄氧基,n为0~6的整数;化合物1为取代罗丹明6G,化合物2为取代苯酰,化合物3为取代酰氯。Wherein, X is selected from O or S; Y is selected from ClO 4 , PF 6 , BF 4 , Cl, Br, I, CF 3 COO, CF 3 SO 3 , CH 3 COO or CH 3 SO 3 ; R 1 is selected from H , OH, OCH 3 or N[(CH 2 )nCH 3 ] 2 ; R 2 and R 3 are H, o-carboxyphenyl or phenyl or o-methylphenyl, R 4 is substituted benzyloxy, optional From 4-nitrobenzyloxy, 4-phosphobenzyloxy, 4-glutamyl transpeptidylbenzyloxy, 4-β-galactosylbenzyloxy, azidobenzyloxy, 2,4- Dinitrobenzyloxy, 4-boronic acid benzyloxy or 4-boronic acid benzyloxy, n is an integer from 0 to 6; compound 1 is substituted rhodamine 6G, compound 2 is substituted benzoyl, compound 3 is substituted acid chloride.
具体的合成步骤为:Concrete synthetic steps are:
(1)中间体1的合成:(1) Synthesis of Intermediate 1:
将取代罗丹明6G(化合物1)溶于氢氧化钠和乙醇混合溶液中,在150~170℃下反应36~48小时;冷却后用盐酸溶液调节pH至3~4,析出固体过滤,得到中间产物1;Dissolve substituted rhodamine 6G (compound 1) in a mixed solution of sodium hydroxide and ethanol, and react at 150-170°C for 36-48 hours; after cooling, adjust the pH to 3-4 with hydrochloric acid solution, precipitate the solid and filter to obtain intermediate Product 1;
(2)中间体2的合成:(2) Synthesis of Intermediate 2:
将中间体1、环己酮溶于浓硫酸中,于80~100℃下反应1~3小时,冷却至室温后加入冰水,加入质子酸,析出固体过滤,得到中间体2;Dissolve intermediate 1 and cyclohexanone in concentrated sulfuric acid, react at 80-100°C for 1-3 hours, cool to room temperature, add ice water, add protonic acid, precipitate solid and filter to obtain intermediate 2;
其中,所述质子酸可选自HClO4、HPF6、HBF4、HCl、HBr、HI、CF3COOH、CF3SO3H和CH3SO3H中的一种;其中,中间产物1和环己酮的投料摩尔比为1:(1~3);Wherein, the protic acid can be selected from one of HClO 4 , HPF 6 , HBF 4 , HCl, HBr, HI, CF 3 COOH, CF 3 SO 3 H and CH 3 SO 3 H; wherein, the intermediate product 1 and The molar ratio of cyclohexanone is 1:(1~3);
(3)中间体3的合成(3) Synthesis of intermediate 3
将取代苯酰(化合物2)溶于浓硫酸中,于80~100℃下反应1~3小时,冷却至室温后加入冰水,加入质子酸,析出固体过滤得到中间体3;中间产物2和环己酮的投料摩尔比为1:(1~3);Dissolve substituted benzoyl (compound 2) in concentrated sulfuric acid, react at 80-100°C for 1-3 hours, add ice water after cooling to room temperature, add protonic acid, precipitate solid and filter to obtain intermediate 3; intermediate 2 and The molar ratio of cyclohexanone is 1:(1~3);
其中,所述质子酸可选自HClO4、HPF6、HBF4、HCl、HBr、HI、CF3COOH、CF3SO3H和CH3SO3H中的一种;Wherein, the protonic acid can be selected from one of HClO 4 , HPF 6 , HBF 4 , HCl, HBr, HI, CF 3 COOH, CF 3 SO 3 H and CH 3 SO 3 H;
(4)中间体4的合成:(4) Synthesis of Intermediate 4:
将中间体3、丙二醛二缩苯胺盐酸盐溶于醋酸和醋酸酐混合溶剂中,在氮气保护下,于90~110℃下反应1~3小时;冷却至室温后,有机相浓缩并用柱色谱分离,得到中间体4;Dissolve intermediate 3, malondialdehyde dianiline hydrochloride in a mixed solvent of acetic acid and acetic anhydride, and react at 90-110°C for 1-3 hours under nitrogen protection; after cooling to room temperature, concentrate the organic phase and use Column chromatography separation, obtains intermediate 4;
(5)中间体5的合成:(5) Synthesis of Intermediate 5:
在氮气保护下,将中间体2、中间体4加入到甲苯和正丁醇混合溶剂中,于80~120℃下反应3~6小时;冷却至室温后,有机相浓缩,并用柱色谱分离,得到中间体5;中间体2和中间产物4的投料摩尔比为1:(1~3);Under the protection of nitrogen, add intermediate 2 and intermediate 4 into a mixed solvent of toluene and n-butanol, and react at 80-120°C for 3-6 hours; after cooling to room temperature, the organic phase is concentrated and separated by column chromatography to obtain Intermediate 5; the molar ratio of intermediate 2 and intermediate product 4 is 1:(1~3);
(6)比率型近红外荧光探针分子(产物1)的合成:(6) Synthesis of ratiometric near-infrared fluorescent probe molecules (product 1):
将中间体5和取代酰氯(化合物3)溶于二氯甲烷,加入有机碱,室温反应12~48h;淬灭反应后,有机相浓缩,并用柱色谱分离,得到产物1;中间体5和取代酰氯的投料摩尔比为1:(2~3)。Dissolve intermediate 5 and substituted acid chloride (compound 3) in dichloromethane, add an organic base, and react at room temperature for 12 to 48 hours; after quenching the reaction, the organic phase is concentrated and separated by column chromatography to obtain product 1; intermediate 5 and substituted The feeding molar ratio of acid chloride is 1:(2~3).
其中,所述有机碱选自三乙胺,N,N-二异丙基乙胺,吡啶中的一种。Wherein, the organic base is selected from one of triethylamine, N,N-diisopropylethylamine and pyridine.
本发明所得到的比率型近红外第二窗口荧光探针分子与酶、活性氧/活性氮(ROS/RNS)作用后产生比率荧光信号。The ratio-type near-infrared second-window fluorescent probe molecules obtained in the present invention interact with enzymes and active oxygen/nitrogen (ROS/RNS) to generate ratio fluorescence signals.
本发明提供的比率型近红外第二窗口荧光探针分子,其摩尔消光系数大,吸收、发射波长长,具有较好的化学稳定性和光稳定性,在较大的酸碱范围内也具有很好的稳定性。该平台分子通用性好,可用于构建各种酶响应以及活性氧响应的比率型近红外荧光探针,因此可以在生物活体内实现(半)定量可视化监测生物小分子(活性氧)、大分子(酶)等。The ratio-type near-infrared second window fluorescent probe molecule provided by the present invention has a large molar extinction coefficient, long absorption and emission wavelengths, good chemical stability and photostability, and also has a large range of acid and alkali. good stability. The platform has good molecular versatility and can be used to construct ratiometric near-infrared fluorescent probes that respond to various enzymes and reactive oxygen species. Therefore, it can realize (semi) quantitative and visual monitoring of biological small molecules (reactive oxygen species) and macromolecules in vivo. (enzymes) etc.
进一步地,本发明的比率型近红外荧光探针分子(通式1),在二氯甲烷溶液中,最大吸收峰位于~800nm,最大发射峰位于~950nm。Furthermore, the ratiometric near-infrared fluorescent probe molecule (general formula 1) of the present invention has a maximum absorption peak at ~800nm and a maximum emission peak at ~950nm in a dichloromethane solution.
进一步地,本发明的比率型近红外荧光探针分子(通式1),在二氯甲烷溶液中的摩尔消光系数为~95000M-1cm-1。Furthermore, the molar extinction coefficient of the ratiometric near-infrared fluorescent probe molecule (general formula 1) of the present invention in a dichloromethane solution is ~95000M -1 cm -1 .
本发明提供的比率型近红外荧光探针分子,可用于生物体深组织成像、生物传感分析等,例如制成试剂或胶束溶液等。The ratiometric near-infrared fluorescent probe molecules provided by the present invention can be used for deep tissue imaging of organisms, biosensing analysis, etc., for example, to be prepared as reagents or micellar solutions.
附图说明Description of drawings
图1为808nm激发,比率型近红外荧光探针Rap-N在PBS溶液(PBS/glycerol/PEG400)中的吸收和荧光发射谱图(对应实施例1)。Fig. 1 is the absorption and fluorescence emission spectrum (corresponding to Example 1) of ratiometric near-infrared fluorescent probe Rap-N in PBS solution (PBS/glycerol/PEG400) excited at 808 nm.
图2为808nm激发,比率型近红外荧光探针Rap-N对硝基还原酶响应的荧光比率变化谱图(对应实施例1)。Fig. 2 is the fluorescence ratio change spectrogram (corresponding to Example 1) of the ratiometric near-infrared fluorescent probe Rap-N in response to nitroreductase when excited at 808 nm.
图3为808nm激发,比率型近红外荧光探针Rap-R对过氧化氢响应的荧光比率变化谱图(对应实施例2)。Fig. 3 is the fluorescence ratio change spectrogram (corresponding to Example 2) of the ratiometric near-infrared fluorescent probe Rap-R in response to hydrogen peroxide excited at 808 nm.
图4为Rap-N探针用于活体肿瘤成像(对应实施例4)。Fig. 4 is the Rap-N probe used for tumor imaging in vivo (corresponding to Example 4).
图5为Rap-R探针用于活体肝损伤成像(对应实施例5)。Fig. 5 shows that the Rap-R probe is used for liver injury imaging in vivo (corresponding to Example 5).
具体实施方式Detailed ways
为了使本发明的目的、技术方案及优点更加清楚明白,本发明用以下具体实施例进行说明,但本发明绝非限于这些实施例。以下所述仅为本发明较好的实施例,仅用于解释本发明,并不能因此而理解为对本发明专利范围的限制。应当指出的是,凡是本发明的精神和原则之内所做的任何修改、替代或改进均应包含在本发明的保护范围之内。In order to make the object, technical solution and advantages of the present invention more clear, the present invention is illustrated with the following specific examples, but the present invention is by no means limited to these examples. The following descriptions are only preferred embodiments of the present invention, and are only used to explain the present invention, and should not be construed as limiting the patent scope of the present invention. It should be noted that any modification, substitution or improvement made within the spirit and principle of the present invention shall be included within the protection scope of the present invention.
实施例1:Example 1:
硝基还原酶(NTR)响应的比率型近红外荧光探针(记为Rap-N)的制备,化合物的结构式如下:Preparation of the ratiometric near-infrared fluorescent probe (referred to as Rap-N) of nitroreductase (NTR) response, the structural formula of the compound is as follows:
具体合成路线如下:Concrete synthetic route is as follows:
具体合成步骤如下:Concrete synthetic steps are as follows:
(1)中间体1的合成(1) Synthesis of intermediate 1
将罗丹明6G(化合物1)溶于氢氧化钠和乙醇混合溶液中,在150~170℃下反应36~48小时;冷却后用盐酸溶液调节pH至3~4,析出固体过滤得到中间产物1;Dissolve rhodamine 6G (compound 1) in a mixed solution of sodium hydroxide and ethanol, react at 150-170°C for 36-48 hours; after cooling, adjust the pH to 3-4 with hydrochloric acid solution, precipitate solids and filter to obtain intermediate product 1 ;
(2)中间体2的合成(2) Synthesis of Intermediate 2
将中间体1、环己酮溶于浓硫酸中,于80~100℃下反应1~3小时,冷却至室温后加入冰水,加入HClO4;析出固体过滤得到中间体2;其中中间产物1和环己酮的投料摩尔比为1:(1~3);Dissolve intermediate 1 and cyclohexanone in concentrated sulfuric acid, react at 80-100°C for 1-3 hours, add ice water after cooling to room temperature, and add HClO 4 ; the precipitated solid is filtered to obtain intermediate 2; intermediate product 1 The molar ratio of feeding with cyclohexanone is 1:(1~3);
(3)中间体3的合成(3) Synthesis of intermediate 3
将化合物2溶于浓硫酸中,于80~100℃下反应1~3小时,冷却至室温后加入冰水,加入HClO4;析出固体过滤得到中间体3;其中中间产物2和环己酮的投料摩尔比为1:(1~3);Dissolve compound 2 in concentrated sulfuric acid, react at 80-100°C for 1-3 hours, add ice water after cooling to room temperature, and add HClO 4 ; the precipitated solid is filtered to obtain intermediate 3; the intermediate product 2 and cyclohexanone The molar ratio of feeding is 1:(1~3);
(4)中间体4的合成(4) Synthesis of Intermediate 4
将中间体3、丙二醛二缩苯胺盐酸盐溶于醋酸和醋酸酐混合溶剂中,在氮气保护下,于90~110℃下反应1~3小时;冷却至室温后,有机相浓缩并用柱色谱分离得到中间体4;Dissolve intermediate 3, malondialdehyde dianiline hydrochloride in a mixed solvent of acetic acid and acetic anhydride, and react at 90-110°C for 1-3 hours under nitrogen protection; after cooling to room temperature, concentrate the organic phase and use Column chromatography separation obtains intermediate 4;
(5)中间体5的合成(5) Synthesis of intermediate 5
在氮气保护下,将中间体2、中间体4加入到甲苯和正丁醇混合溶剂中,于80~120℃下反应3~6小时;冷却至室温后,有机相浓缩并用柱色谱分离,得到中间体5;其中中间产物2和中间产物4的投料摩尔比为1:(1~3);Under the protection of nitrogen, add intermediate 2 and intermediate 4 into a mixed solvent of toluene and n-butanol, and react at 80-120°C for 3-6 hours; after cooling to room temperature, the organic phase is concentrated and separated by column chromatography to obtain intermediate body 5; wherein the molar ratio of intermediate product 2 and intermediate product 4 is 1:(1~3);
(6)Rap-N的合成(6) Synthesis of Rap-N
将中间体5和氯甲酸对硝基苄酯溶于二氯甲烷,加入三乙胺,室温反应12~48h;淬灭反应后,有机相浓缩并用柱色谱分离,得到最终产物Rap-N;其中,中间体5和氯甲酸对硝基苄酯的投料摩尔比为1:(2~3)。Dissolve intermediate 5 and p-nitrobenzyl chloroformate in dichloromethane, add triethylamine, and react at room temperature for 12-48 hours; after quenching the reaction, the organic phase is concentrated and separated by column chromatography to obtain the final product Rap-N; , the molar ratio of intermediate 5 and p-nitrobenzyl chloroformate is 1:(2~3).
具体例子:Concrete example:
(1)中间体1的合成(1) Synthesis of Intermediate 1
将罗丹明6G(化合物1)溶于氢氧化钠和乙醇混合溶液中,在170℃下反应36小时;冷却后用盐酸溶液调节pH至约3~4,析出固体过滤得到中间产物1;Rhodamine 6G (compound 1) was dissolved in a mixed solution of sodium hydroxide and ethanol, and reacted at 170°C for 36 hours; after cooling, the pH was adjusted to about 3-4 with hydrochloric acid solution, and the precipitated solid was filtered to obtain intermediate product 1;
(2)中间体2的合成(2) Synthesis of intermediate 2
将中间体1、环己酮溶于浓硫酸中,于90℃下反应2小时,冷却至室温后加入冰水,加入HClO4;析出固体过滤得到中间体2;其中中间产物1和环己酮的投料摩尔比为1:1.2;Dissolve intermediate 1 and cyclohexanone in concentrated sulfuric acid, react at 90°C for 2 hours, add ice water after cooling to room temperature, and add HClO 4 ; the precipitated solid is filtered to obtain intermediate 2; intermediate product 1 and cyclohexanone The feeding molar ratio is 1:1.2;
(3)中间体3的合成(3) Synthesis of intermediate 3
将化合物2溶于浓硫酸中,于90℃下反应2小时,冷却至室温后加入冰水,加入HClO4;析出固体过滤得到中间体3;其中中间产物2和环己酮的投料摩尔比为1:1.2;Dissolve compound 2 in concentrated sulfuric acid, react at 90°C for 2 hours, add ice water after cooling to room temperature, and add HClO 4 ; the precipitated solid is filtered to obtain intermediate 3; wherein the molar ratio of intermediate product 2 and cyclohexanone is 1:1.2;
(4)中间体4的合成(4) Synthesis of Intermediate 4
将中间体3、丙二醛二缩苯胺盐酸盐溶于醋酸和醋酸酐混合溶剂中,在氮气保护下,于100℃下反应2小时;冷却至室温后,有机相浓缩并用柱色谱分离得到中间体4;Dissolve intermediate 3, malondialdehyde dianiline hydrochloride in a mixed solvent of acetic acid and acetic anhydride, and react at 100°C for 2 hours under nitrogen protection; after cooling to room temperature, the organic phase is concentrated and separated by column chromatography to obtain Intermediate 4;
(5)中间体5的合成(5) Synthesis of intermediate 5
在氮气保护下,将中间体2、中间体4加入到甲苯和正丁醇混合溶剂中,于110℃下反应5小时;冷却至室温后,有机相浓缩并用柱色谱分离,得到中间体5;其中中间产物2和中间产物4的投料摩尔比为1:1;Under nitrogen protection, intermediate 2 and intermediate 4 were added to a mixed solvent of toluene and n-butanol, and reacted at 110°C for 5 hours; after cooling to room temperature, the organic phase was concentrated and separated by column chromatography to obtain intermediate 5; The molar ratio of intermediate product 2 and intermediate product 4 is 1:1;
(6)Rap-N的合成(6) Synthesis of Rap-N
将中间体5和氯甲酸对硝基苄酯溶于二氯甲烷,加入三乙胺,室温反应24小时;淬灭反应后,有机相浓缩并用柱色谱分离,得到最终产物Rap-N;其中,中间体5和氯甲酸对硝基苄酯的投料摩尔比为1:1。Dissolve intermediate 5 and p-nitrobenzyl chloroformate in dichloromethane, add triethylamine, and react at room temperature for 24 hours; after quenching the reaction, the organic phase is concentrated and separated by column chromatography to obtain the final product Rap-N; wherein, The molar ratio of intermediate 5 and p-nitrobenzyl chloroformate is 1:1.
在808nm激发下,Rap-N比率荧光探针对硝基还原酶响应的荧光强度变化,见图2所示。Under the excitation of 808nm, the change of fluorescence intensity of Rap-N ratiometric fluorescent probe in response to nitroreductase is shown in Figure 2.
实施例2:Example 2:
活性氧响应的比率型近红外荧光探针(记为Rap-R)的制备,化合物的结构式如下:The preparation of the ratiometric near-infrared fluorescent probe (referred to as Rap-R) of active oxygen response, the structural formula of the compound is as follows:
具体合成路线如下:Concrete synthetic route is as follows:
具体合成步骤如下:Concrete synthetic steps are as follows:
(1)中间体1的合成(1) Synthesis of Intermediate 1
将罗丹明6G(化合物1)溶于氢氧化钠和乙醇混合溶液中,在150~170℃下反应36~48小时;冷却后用盐酸溶液调节pH至3~4,析出固体过滤得到中间产物1;Dissolve rhodamine 6G (compound 1) in a mixed solution of sodium hydroxide and ethanol, react at 150-170°C for 36-48 hours; after cooling, adjust the pH to 3-4 with hydrochloric acid solution, precipitate solids and filter to obtain intermediate product 1 ;
(2)中间体2的合成(2) Synthesis of intermediate 2
将中间体1、环己酮溶于浓硫酸中,于80~100℃下反应1~3小时,冷却至室温后加入冰水,加入HClO4;析出固体过滤得到中间体2;其中中间产物1和环己酮的投料摩尔比为1:(1~3);Dissolve intermediate 1 and cyclohexanone in concentrated sulfuric acid, react at 80-100°C for 1-3 hours, add ice water after cooling to room temperature, and add HClO 4 ; the precipitated solid is filtered to obtain intermediate 2; intermediate product 1 The molar ratio of feeding with cyclohexanone is 1:(1~3);
(3)中间体3的合成(3) Synthesis of intermediate 3
将化合物2溶于浓硫酸中,于80~100℃下反应1~3小时,冷却至室温后加入冰水,加入HClO4;析出固体过滤得到中间体3;其中中间产物2和环己酮的投料摩尔比为1:(1~3);Dissolve compound 2 in concentrated sulfuric acid, react at 80-100°C for 1-3 hours, add ice water after cooling to room temperature, and add HClO 4 ; the precipitated solid is filtered to obtain intermediate 3; the intermediate product 2 and cyclohexanone The molar ratio of feeding is 1:(1~3);
(4)中间体4的合成(4) Synthesis of Intermediate 4
将中间体3、丙二醛二缩苯胺盐酸盐溶于醋酸和醋酸酐混合溶剂中,在氮气保护下,于90~110℃下反应1~3小时;冷却至室温后,有机相浓缩并用柱色谱分离得到中间体4;Dissolve intermediate 3, malondialdehyde dianiline hydrochloride in a mixed solvent of acetic acid and acetic anhydride, and react at 90-110°C for 1-3 hours under nitrogen protection; after cooling to room temperature, concentrate the organic phase and use Column chromatography separation obtains intermediate 4;
(5)中间体5的合成(5) Synthesis of intermediate 5
在氮气保护下,将中间体2、中间体4加入到甲苯和正丁醇混合溶剂中,于80~120℃下反应3~6小时;冷却至室温后,有机相浓缩并用柱色谱分离,得到中间体5;其中,中间产物2和中间产物4的投料摩尔比为1:(1~3);Under the protection of nitrogen, add intermediate 2 and intermediate 4 into a mixed solvent of toluene and n-butanol, and react at 80-120°C for 3-6 hours; after cooling to room temperature, the organic phase is concentrated and separated by column chromatography to obtain intermediate body 5; wherein, the molar ratio of intermediate product 2 and intermediate product 4 is 1:(1~3);
(6)Rap-R的合成(6) Synthesis of Rap-R
将中间体5和4-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)苄基氯甲酸酯溶于二氯甲烷,加入三乙胺,室温反应12~48h;淬灭反应后,有机相浓缩并用柱色谱分离,得到最终产物Rap-R;其中中间体5和4-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)苄基氯甲酸酯的投料摩尔比为1:(2~3)。Intermediate 5 and 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl chloroformate were dissolved in dichloromethane, Add triethylamine and react at room temperature for 12 to 48 hours; after quenching the reaction, the organic phase is concentrated and separated by column chromatography to obtain the final product Rap-R; wherein intermediate 5 and 4-(4,4,5,5-tetramethyl The molar ratio of -1,3,2-dioxaborolan-2-yl)benzyl chloroformate is 1:(2~3).
具体例子:Concrete example:
(1)中间体1的合成(1) Synthesis of Intermediate 1
将罗丹明6G(化合物1)溶于氢氧化钠和乙醇混合溶液中,在160℃下反应48小时;冷却后用盐酸溶液调节pH至约3~4,析出固体过滤得到中间产物1;Rhodamine 6G (compound 1) was dissolved in a mixed solution of sodium hydroxide and ethanol, and reacted at 160°C for 48 hours; after cooling, the pH was adjusted to about 3-4 with hydrochloric acid solution, and the precipitated solid was filtered to obtain intermediate product 1;
(2)中间体2的合成(2) Synthesis of intermediate 2
将中间体1、环己酮溶于浓硫酸中,于95℃下反应1.5小时,冷却至室温后加入冰水,加入HClO4;析出固体过滤得到中间体2;其中中间产物1和环己酮的投料摩尔比为1:1.3;Dissolve intermediate 1 and cyclohexanone in concentrated sulfuric acid, react at 95°C for 1.5 hours, add ice water after cooling to room temperature, and add HClO 4 ; the precipitated solid is filtered to obtain intermediate 2; intermediate product 1 and cyclohexanone The feeding molar ratio is 1:1.3;
(3)中间体3的合成(3) Synthesis of intermediate 3
将化合物2溶于浓硫酸中,于95℃下反应1.5小时,冷却至室温后加入冰水,加入HClO4;析出固体过滤得到中间体3;其中中间产物2和环己酮的投料摩尔比为1:1.3;Dissolve compound 2 in concentrated sulfuric acid, react at 95°C for 1.5 hours, add ice water after cooling to room temperature, and add HClO 4 ; the precipitated solid is filtered to obtain intermediate 3; wherein the molar ratio of intermediate product 2 and cyclohexanone is 1:1.3;
(4)中间体4的合成(4) Synthesis of Intermediate 4
将中间体3、丙二醛二缩苯胺盐酸盐溶于醋酸和醋酸酐混合溶剂中,在氮气保护下,于110℃下反应2小时;冷却至室温后,有机相浓缩并用柱色谱分离得到中间体4;Dissolve intermediate 3, malondialdehyde dianiline hydrochloride in a mixed solvent of acetic acid and acetic anhydride, and react at 110°C for 2 hours under the protection of nitrogen; after cooling to room temperature, the organic phase is concentrated and separated by column chromatography to obtain Intermediate 4;
(5)中间体5的合成(5) Synthesis of intermediate 5
在氮气保护下,将中间体2、中间体4加入到甲苯和正丁醇混合溶剂中,于100℃下反应6小时;冷却至室温后,有机相浓缩并用柱色谱分离,得到中间体5;其中,中间产物2和中间产物4的投料摩尔比为1:2;Under nitrogen protection, intermediate 2 and intermediate 4 were added to a mixed solvent of toluene and n-butanol, and reacted at 100°C for 6 hours; after cooling to room temperature, the organic phase was concentrated and separated by column chromatography to obtain intermediate 5; , the molar ratio of intermediate product 2 and intermediate product 4 is 1:2;
(6)Rap-R的合成(6) Synthesis of Rap-R
将中间体5和4-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)苄基氯甲酸酯溶于二氯甲烷,加入三乙胺,室温反应24小时;淬灭反应后,有机相浓缩并用柱色谱分离,得到最终产物Rap-R;其中中间体5和4-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)苄基氯甲酸酯的投料摩尔比为1:3。Intermediate 5 and 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl chloroformate were dissolved in dichloromethane, Add triethylamine and react at room temperature for 24 hours; after quenching the reaction, the organic phase is concentrated and separated by column chromatography to obtain the final product Rap-R; wherein intermediate 5 and 4-(4,4,5,5-tetramethyl- The molar ratio of 1,3,2-dioxaborolan-2-yl)benzyl chloroformate is 1:3.
在808nm激发下,Rap-R比率荧光探针对过氧化氢响应的荧光强度变化,见图3所示。Under 808nm excitation, the change of fluorescence intensity of Rap-R ratiometric fluorescent probe in response to hydrogen peroxide is shown in Figure 3.
实施例3:Example 3:
活性氧响应的比率型近红外荧光探针(Rap-R)与磷脂聚乙二醇形成胶束的制备方法,具体步骤如下:The ratio-type near-infrared fluorescent probe (Rap-R) of active oxygen response and the preparation method of phospholipid polyethylene glycol form micelles, the specific steps are as follows:
将荧光探针Rap-R和DOPE-PEG2000溶于氯仿中,两者的质量比为1:(20~100),搅拌0.5~2小时后,旋干溶剂,真空干燥,加热至50~80℃后加入去离子水溶解,超声,冷却至室温后再通过超滤管超滤浓缩,最终得到Rap-R胶束溶液。Dissolve the fluorescent probe Rap-R and DOPE-PEG 2000 in chloroform, the mass ratio of the two is 1:(20-100), after stirring for 0.5-2 hours, spin to dry the solvent, dry in vacuum, and heat to 50-80 After ℃, add deionized water to dissolve, sonicate, cool to room temperature, and then concentrate by ultrafiltration through an ultrafiltration tube to finally obtain Rap-R micellar solution.
实施例4:Example 4:
硝基还原酶响应的比率型近红外荧光探针Rap-N用于监测肿瘤中的硝基还原酶。具体步骤如下:Nitroreductase-responsive ratiometric near-infrared fluorescent probe Rap-N was used to monitor nitroreductase in tumors. Specific steps are as follows:
在麻醉的小鼠肿瘤处注射200μL浓度为100μM的Rap-N探针溶液,用808nm外置激光器照射小鼠肿瘤处,激光器功率密度为200mW/cm2,使用900nm和1000nm长通分滤光片别收集900-1700nm和1000-1700nm的荧光并计算两者强度比值,根据不同肿瘤的荧光信号比率值来监测其硝基还原酶的含量,参见图4所示。图4中,Rap-N探针用于监测4T1肿瘤和CT26肿瘤中硝基还原酶的含量,根据其荧光信号比率值来判断肿瘤中硝基还原酶的含量。Inject 200 μL of Rap-N probe solution with a concentration of 100 μM into the tumor of anesthetized mice, and irradiate the mouse tumor with an external 808nm laser with a laser power density of 200mW/cm 2 , using 900nm and 1000nm long-pass filters Fluorescence at 900-1700nm and 1000-1700nm were collected respectively and the intensity ratio of the two was calculated, and the content of nitroreductase was monitored according to the ratio of fluorescence signals of different tumors, as shown in Figure 4. In Fig. 4, the Rap-N probe was used to monitor the content of nitroreductase in 4T1 tumor and CT26 tumor, and the content of nitroreductase in the tumor was judged according to the ratio of fluorescence signals.
实施例5:Example 5:
活性氧响应的比率型近红外荧光探针Rap-R用于检测炎症组织中活性氧(过氧化氢)的含量。具体步骤如下:Rap-R, a ratiometric near-infrared fluorescent probe responsive to reactive oxygen species, was used to detect the content of reactive oxygen species (hydrogen peroxide) in inflamed tissues. Specific steps are as follows:
在麻醉的小鼠尾静脉处注射200μL浓度为100μM的Rap-R探针胶束溶液,用808nm外置激光器照射小鼠腹部处,激光器功率密度为200mW/cm2,使用900nm和1000nm长通分滤光片别收集900-1700nm和1000-1700nm的荧光并计算两者强度比值,根据不荧光信号比率值来监测肝损伤炎症活性氧(过氧化氢)的含量,参见图5所示。图5中,Rap-R探针用于监测活体肝损伤炎症活性氧(过氧化氢)的含量,根据其荧光信号比率值来判断活性氧(过氧化氢)的含量,分别为对照组,肝损伤及药物治疗后的活性氧(过氧化氢)的含量情况。Inject 200 μL of Rap-R probe micellar solution with a concentration of 100 μM into the tail vein of anesthetized mice, and irradiate the mouse abdomen with an 808nm external laser with a laser power density of 200mW/cm 2 , using 900nm and 1000nm long-pass Filters collect the fluorescence at 900-1700nm and 1000-1700nm respectively and calculate the intensity ratio of the two, and monitor the content of reactive oxygen species (hydrogen peroxide) in liver injury inflammation according to the ratio of non-fluorescence signals, as shown in Figure 5. In Figure 5, the Rap-R probe is used to monitor the content of reactive oxygen species (hydrogen peroxide) in liver injury in vivo, and the content of reactive oxygen species (hydrogen peroxide) is judged according to the ratio of the fluorescence signal. The content of active oxygen (hydrogen peroxide) after injury and drug treatment.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211280811.2A CN115925667B (en) | 2022-10-19 | 2022-10-19 | Ratio type near infrared fluorescent probe molecule and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211280811.2A CN115925667B (en) | 2022-10-19 | 2022-10-19 | Ratio type near infrared fluorescent probe molecule and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115925667A true CN115925667A (en) | 2023-04-07 |
CN115925667B CN115925667B (en) | 2024-02-02 |
Family
ID=86551323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211280811.2A Active CN115925667B (en) | 2022-10-19 | 2022-10-19 | Ratio type near infrared fluorescent probe molecule and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115925667B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108997771A (en) * | 2018-06-12 | 2018-12-14 | 大连理工大学 | One kind has the strong dyestuff and the preparation method and application thereof absorbed with photo-thermal effect near infrared region |
CN109400572A (en) * | 2018-11-03 | 2019-03-01 | 复旦大学 | The fluorescent dye and its preparation method and application of the second window of near-infrared transmitting |
CN112225721A (en) * | 2020-10-21 | 2021-01-15 | 复旦大学 | Acid-responsive near-infrared lysosome organic small-molecule fluorescent probe and preparation method and application thereof |
-
2022
- 2022-10-19 CN CN202211280811.2A patent/CN115925667B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108997771A (en) * | 2018-06-12 | 2018-12-14 | 大连理工大学 | One kind has the strong dyestuff and the preparation method and application thereof absorbed with photo-thermal effect near infrared region |
CN109400572A (en) * | 2018-11-03 | 2019-03-01 | 复旦大学 | The fluorescent dye and its preparation method and application of the second window of near-infrared transmitting |
CN112225721A (en) * | 2020-10-21 | 2021-01-15 | 复旦大学 | Acid-responsive near-infrared lysosome organic small-molecule fluorescent probe and preparation method and application thereof |
Non-Patent Citations (2)
Title |
---|
EMILY D. COSCO等: "Bright Chromenylium Polymethine Dyes Enable Fast, Four-Color In Vivo Imaging with Shortwave Infrared Detection", 《JOURNAL OF THE AMERICAN CHEMICAL SOCIETY》, pages 6836 * |
KATARZYNA GORSKA等: "DNA-templated release of functional molecules with an azide-reductiontriggered immolative linker", 《CHEMCOMM》, pages 4364 * |
Also Published As
Publication number | Publication date |
---|---|
CN115925667B (en) | 2024-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Liu et al. | “Dual-key-and-lock” ruthenium complex probe for lysosomal formaldehyde in cancer cells and tumors | |
Chen et al. | Fluorescent chemodosimeters for fluoride ions via silicon-fluorine chemistry: 20 years of progress | |
Peneva et al. | Water-soluble monofunctional perylene and terrylene dyes: powerful labels for single-enzyme tracking | |
Myochin et al. | Rational design of ratiometric near-infrared fluorescent pH probes with various p K a values, based on aminocyanine | |
EP2259061A2 (en) | Boronic acid derivatives | |
CN112442056B (en) | Fluorescent probe for simultaneously detecting hypochlorous acid and peroxynitrite anions, and synthetic method and application thereof | |
CN106892947B (en) | One kind containing the complex of iridium and its preparation method and application of (Hydrazinocarbonyl) ferrocene ligands | |
CN106699734B (en) | Fluorescent molecular probe and nano probe as well as preparation method and application thereof | |
CN113292582B (en) | Synthesis and Application of a Bifunctional Fluorescent Probe for Distinguishing Hydroxyl Radical and Hydrogen Peroxide Simultaneously | |
CN103409135A (en) | Rhodamine fluorescent molecular probe using quinoline derivative as identification group and synthesis method thereof | |
CN111362971A (en) | PSMA-targeting bisbenzothiadiazole compounds, preparation method and application thereof | |
CN113956265A (en) | Near-infrared molecular probe based on malondialdehyde response, preparation method and application thereof | |
CN110563708B (en) | Turn-on type fluorescent probe for rapidly detecting sulfite (hydrogen) salt, and synthesis method and application thereof | |
CN110194951B (en) | Tetraphenyl ethylene derivative fluorescent probe and preparation method thereof | |
CN106497547B (en) | A kind of rare earth luminescent material and preparation method thereof, application | |
CN115925667B (en) | Ratio type near infrared fluorescent probe molecule and preparation method and application thereof | |
CN112961671B (en) | Fluorescent/phosphorescent light-emitting life polymer probe capable of simultaneously detecting multiple targets and application thereof | |
CN113307803B (en) | A NIR-II AIE molecule with excellent properties and its application | |
CN109678993B (en) | Internal standard ratio type nano fluorescent probe for reversible hypoxic-normoxic cycle detection, preparation method and application thereof | |
CN108727277B (en) | A highly selective aggregation-induced chemiluminescence probe for singlet oxygen and its preparation method and application | |
CN113527364B (en) | Mn (II) complex multi-photon absorption material and preparation method and application thereof | |
CN110669350B (en) | Piperidyl BODIPY red-light fluorescent dye and preparation method and application thereof | |
WO2023040089A1 (en) | Fluorescent compound and probe | |
CN114605376A (en) | A bifunctional fluorescent probe for detecting cysteine and viscosity and its preparation | |
CN114835629B (en) | A kind of carbazole benzo[cd]indolium salt and its preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |